Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Confirmatory Efficacy and Safety Trial of Remimazolam (CNS7056) Compared With Propofol for Intravenous Anesthesia During Elective Surgery in ASA Class III/IV Patients

NCT03661489 is registered in ClinicalTrials.gov with Paion UK Ltd. as lead sponsor.

NCT NCT03661489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03661489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Confirmatory Efficacy and Safety Trial of Remimazolam (CNS7056) Compared With Propofol for Intravenous Anesthesia During Elective Surgery in ASA Class III/IV Patients
Lead sponsor
Paion UK Ltd.
Phase
Phase 3
Overall status
Completed
Start date
July 24, 2018
Completion date
April 2, 2020
Enrollment
469 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, intravenous